Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis

A Bossowski1, B Czarnocka, K Bardadin

  • 12nd Department of Children's Diseases, Medical University of Bialystok, Bialystok, Poland. abossowski@hotmail.com

Autoimmunity
|March 8, 2008
PubMed

Insights

Apoptosis, or programmed cell death, is crucial for health. This study found increased expression of Fas/FasL and caspase-8 in Graves' disease and Hashimoto's thyroiditis, suggesting their role in autoimmune thyroid disease pathogenesis.

Area of Science:

  • Endocrinology
  • Immunology
  • Cell Biology

Background:

  • Apoptosis (programmed cell death) is vital for organism function.
  • Dysregulation of apoptosis is implicated in the pathogenesis of various diseases, including autoimmune thyroid disorders.
  • Understanding apoptosis in thyroid tissue is key to understanding thyroid disease.

Purpose of the Study:

  • To evaluate the expression of Fas/FasL and caspase-8 in thyroid tissue from patients with Graves' disease (GD), non-toxic nodular goiter (NTNG), and Hashimoto's thyroiditis (HT).
  • To investigate the correlation between apoptotic molecule expression and disease activity markers.
  • To elucidate the role of apoptosis in the pathogenesis of autoimmune thyroid diseases.

Main Methods:

  • Western blot and immunohistochemical analysis were used to assess Fas/FasL expression.
  • Western blot was employed to assay caspase-8 expression in thyroid follicular cells.
  • Patients with GD, NTNG, and HT were included in the study.

Main Results:

  • Proapoptotic proteins FasL and Fas showed significantly higher expression in thyroid tissue of GD and HT patients compared to NTNG patients.
  • Caspase-8 expression was detected in patients with autoimmune thyroid diseases.
  • In GD patients, FasL expression in thyrocytes positively correlated with TRAb levels, but not with thyroid hormones.

Conclusions:

  • Altered expression of apoptotic molecules (Fas/FasL, caspase-8) in thyroid follicular cells and T lymphocytes is involved in the pathogenesis of GD and HT.
  • Assessing Fas/FasL and caspase-8 expression in thyroid tissue may serve as an indicator of disease activity and immunological phenotype in autoimmune thyroid disorders.

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...